Rockville, Md. -- Data should drive the Food and Drug Administration's (FDA) regulatory proposal on appropriate antimicrobial uses in food animals, according to recently released statement from two prominent veterinary organizations.
Rockville, Md.
-- Data should drive the Food and Drug Administration's (FDA) decision on appropriate antimicrobial use in food animals, according to recently released position statement from two prominent veterinary organizations.
The statement released yesterday by the American Association of Bovine Practitioners (AABP) and Academy of Veterinary Consultants (AVC) says:
"The American Association of Bovine Practitioners and the Academy of Veterinary Consultants welcome the opportunity to collaborate with the FDA-CVM on the principles identified in the draft guidance titled 'The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals.' The issues of drug availability for maintaining good animal health, as well as veterinary oversight/consultation for such uses have been priorities for AABP and AVC members for many years.
"Although the AABP and AVC do not agree that the weight of the scientific evidence supports the phasing out of all production indications, we are committed to supporting changes that measurably and positively impact the critical issue of antimicrobial resistance. The AABP and AVC recognize the importance of antimicrobial resistance, and wish to participate in aggressively addressing resistance concerns; however, the organizations remain committed to regulation based on data-based analysis rather than expert consensus. It is imperative that the collaborators approach the issue of production enhancement uses of antimicrobials with the realization that the standards and practices established for these uses will serve as a precedent for evaluating disease prevention, control and therapeutic uses.
"Lastly, in regard to FDA-CVM’s request for comment on enhancing the efficiency of the Veterinary Feed Directive drug program, the AABP and AVC look forward to collaborating with the agency to evaluate potential methods of veterinary oversight, input or consultation for the use of antimicrobials in livestock feeds."
The draft guidance is open for public comment.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More